市场调查报告书
商品编码
1416179
器官保存解决方案市场- 按解决方案(威斯康辛大学、Custodiol HTK、Perfadex、Celsior)、保存类型(静态冷藏、低温、常温)、器官(肾、肝、肺)、最终用户、全球预测(2023年- )第2032章Organ Preservation Solution Market - By Solution (University of Wisconsin, Custodiol HTK, Perfadex, Celsior), Preservation Type (Static Cold Storage, Hypothermic, Normothermic), Organ (Kidney, Liver, Lungs), End-user, Global Forecast (2023-2032) |
在全球器官捐赠知识不断增长的推动下,器官保存解决方案市场规模预计从 2023 年到 2032 年将以超过 6.8% 的CAGR成长。
关于器官捐赠重要性的公众意识活动和教育活动的不断加强导致自愿器官捐赠者的增加。随着越来越多的人了解器官移植对拯救生命的影响,对有效器官保存解决方案的需求正在激增。此外,领先的组织正在强调研发投资,以引入先进的保存解决方案,以提高器官活力和移植成功率。一些企业也正在规划和实施策略性倡议,以简化器官移植流程,进一步促进整个产业的成长。例如,2023年11月,Paragonix Technologies开发了一个全面的供体器官采购、储存和运输服务网络。
器官保存溶液产业分为溶液、保存类型、器官、最终用户和区域。
根据解决方案,由于 perfadex 解决方案在肺移植手术中的广泛使用,预计 2023 年至 2032 年间,其市场份额将以 6.7% 的CAGR获得显着增长。 Perfadex 解决方案拥有独特的成分和促进最佳器官保存的能力,以确保移植期间延长活力。鑑于它们在最大限度地减少缺血再灌注损伤和改善移植后结果方面的有效性,这些解决方案在器官保存领域越来越受到青睐。由于呼吸系统疾病激增,全球肺移植数量不断增加,将推动该领域的成长。
从最终用户来看,医院领域的器官保存解决方案产业在2022 年需求旺盛,预计到2032 年将实现7.3% 的成长率。医院在器官移植手术中发挥关键作用,因为它们需要使用有效的保存解决方案。全球器官移植数量不断增加,加上对改善移植后结果的日益重视,刺激了对高品质保存解决方案的需求。
此外,医院对先进器官保存解决方案的投资不断增加,以增强器官活力、减少缺血再灌注损伤并提高整体移植成功率,将推动该领域的成长。
从地区来看,由于器官衰竭盛行率不断上升以及对移植选择的认识不断增强,亚太器官保存解决方案市场从2023年到2032年的CAGR预计将达到7.5%。 2015年至2022年间,中国报告了约40,200例死者器官捐献,其中120,100例为主要器官。此外,医疗基础设施的改善以及政府加强器官捐赠和移植计划的倡议激增将推动区域市场的扩张。
Organ Preservation Solution Market size is poised to expand at over 6.8% CAGR from 2023 to 2032, driven by the increasing knowledge of organ donation worldwide.
The growing public awareness campaigns and educational initiatives about the importance of organ donation have led to the rise in voluntary organ donors. With more individuals understanding the impacts of organ transplantation on saving lives, the demand for effective organ preservation solutions is surging. Additionally, leading organizations are emphasizing R&D investments to introduce advanced preservation solutions to enhance organ viability and transplantation success. Several businesses are also planning and implementing strategic initiatives to streamline the organ transplantation process, further contributing to the overall industry growth. For instance, in November 2023, Paragonix Technologies developed a comprehensive network of donor organ procurement, storage, and transportation services.
The organ preservation solution industry is segmented into solution, preservation type, organ, end-user, and region.
As per solution, the market share from the perfadex solution segment is projected to gain significant traction at 6.7% CAGR between 2023 and 2032 owing to its widespread use in lung transplantation procedures. Perfadex solutions boast of unique composition and capabilities in facilitating optimal organ preservation for ensuring extended viability during transplantation. Given their effectiveness in minimizing ischemia-reperfusion injuries and improving post-transplant outcomes, these solutions are increasingly preferred in the organ preservation domain. The increasing number of lung transplants across the globe, driven by the jump in rising respiratory disorders will boost the segment growth.
Based on end-user, the organ preservation solution industry from the hospitals segment witnessed high demand in 2022 and is estimated to record 7.3% growth rate through 2032. Hospitals play a pivotal role in organ transplantation procedures as they necessitate the usage of effective preservation solutions. The increasing number of organ transplants across the globe coupled with the growing emphasis on improving post-transplant outcomes is fueling the demand for high-quality preservation solutions.
Furthermore, the rising investments by hospitals on advanced organ preservation solutions to enhance organ viability, reduce ischemia-reperfusion injuries, and improve the overall transplant success rates will boost the segment growth.
Regionally, the Asia Pacific organ preservation solution market is set to exhibit 7.5% CAGR from 2023 to 2032 owing to the rising prevalence of organ failure and the increasing awareness of transplantation options. Between 2015 and 2022, China reported about 40,200 deceased organ donations, of which 120,100 were major organs. Moreover, the improving healthcare infrastructure along with the surge in government initiatives to enhance organ donation and transplantation programs will propel the regional market expansion.